Alexis V Rivera1, Jennifer DeCuir2, Natalie D Crawford3, Silvia Amesty4, Crystal Fuller Lewis5. 1. Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032, USA. Electronic address: avr2107@columbia.edu. 2. Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032, USA; College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA. 3. Division of Epidemiology and Biostatistics, Georgia State University School of Public Health, 1 Park Place, Atlanta, GA 30302, USA. 4. Center for Family and Community Medicine, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA; Heilbrunn Department of Population and Family Health, Mailman School of Public Health, Columbia University, 60 Haven Ave #B2, New York, NY 10032, USA. 5. Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032, USA.
Abstract
BACKGROUND: Little is known on the effect of stigma on the health and behavior of people who inject drugs (PWID). PWID may internalize these negative attitudes and experiences and stigmatize themselves (internalized stigma). With previous research suggesting a harmful effect of internalized stigma on health behaviors, we aimed to determine socio-demographic characteristics and injection risk behaviors associated with internalized PWID-related stigma in New York City (NYC). METHODS: Three NYC pharmacies assisted in recruiting PWID. Pharmacy-recruited PWID syringe customers received training in recruiting up to three of their peers. Participants completed a survey on injection behaviors and PWID-related stigma. Among HIV-negative PWID (n=132), multiple linear regression with GEE (to account for peer network clustering) was used to examine associations with internalized PWID-related stigma. RESULTS: Latinos were more likely to have higher internalized stigma, as were those with lower educational attainment. Those with higher internalized stigma were more likely to not use a syringe exchange program (SEP) recently, although no association was found with the recent use of pharmacies for syringes. Lastly, higher internalized stigma was related to less than 100% use of pharmacies or SEPs for syringe needs. CONCLUSIONS: These data suggest that PWID with higher internalized stigma are less likely to consistently use sterile syringe sources in urban settings with multiple sterile syringe access points. These results support the need for individual- and structural-level interventions that address PWID-related stigma. Future research is needed to examine why PWID with higher internalized stigma have less consistent use of public syringe access venues.
BACKGROUND: Little is known on the effect of stigma on the health and behavior of people who inject drugs (PWID). PWID may internalize these negative attitudes and experiences and stigmatize themselves (internalized stigma). With previous research suggesting a harmful effect of internalized stigma on health behaviors, we aimed to determine socio-demographic characteristics and injection risk behaviors associated with internalized PWID-related stigma in New York City (NYC). METHODS: Three NYC pharmacies assisted in recruiting PWID. Pharmacy-recruited PWID syringe customers received training in recruiting up to three of their peers. Participants completed a survey on injection behaviors and PWID-related stigma. Among HIV-negative PWID (n=132), multiple linear regression with GEE (to account for peer network clustering) was used to examine associations with internalized PWID-related stigma. RESULTS: Latinos were more likely to have higher internalized stigma, as were those with lower educational attainment. Those with higher internalized stigma were more likely to not use a syringe exchange program (SEP) recently, although no association was found with the recent use of pharmacies for syringes. Lastly, higher internalized stigma was related to less than 100% use of pharmacies or SEPs for syringe needs. CONCLUSIONS: These data suggest that PWID with higher internalized stigma are less likely to consistently use sterile syringe sources in urban settings with multiple sterile syringe access points. These results support the need for individual- and structural-level interventions that address PWID-related stigma. Future research is needed to examine why PWID with higher internalized stigma have less consistent use of public syringe access venues.
Authors: K M Keyes; M L Hatzenbuehler; K A McLaughlin; B Link; M Olfson; B F Grant; D Hasin Journal: Am J Epidemiol Date: 2010-11-02 Impact factor: 4.897
Authors: Carl Latkin; Aylur K Srikrishnan; Cui Yang; Sethulakshmi Johnson; Sunil S Solomon; Suresh Kumar; David D Celentano; Suniti Solomon Journal: Drug Alcohol Depend Date: 2010-05-13 Impact factor: 4.492
Authors: Abby E Rudolph; Natalie D Crawford; Danielle C Ompad; Ebele O Benjamin; Rachel J Stern; Crystal M Fuller Journal: J Am Pharm Assoc (2003) Date: 2010 Mar-Apr 1
Authors: Steffanie A Strathdee; Steven Shoptaw; Typhanye Penniman Dyer; Vu Minh Quan; Apinun Aramrattana Journal: Curr Opin HIV AIDS Date: 2012-07 Impact factor: 4.283
Authors: Alexis V Rivera; Jennifer DeCuir; Natalie D Crawford; Silvia Amesty; Katherine Harripersaud; Crystal F Lewis Journal: AIDS Care Date: 2015-01-06
Authors: Dea L Biancarelli; Katie B Biello; Ellen Childs; M Drainoni; Peter Salhaney; Alberto Edeza; Matthew J Mimiaga; Richard Saitz; Angela R Bazzi Journal: Drug Alcohol Depend Date: 2019-03-08 Impact factor: 4.492
Authors: Carl A Latkin; Rachel E Gicquelais; Catie Clyde; Lauren Dayton; Melissa Davey-Rothwell; Danielle German; Seun Falade-Nwulia; Haneefa Saleem; Michael Fingerhood; Karin Tobin Journal: Int J Drug Policy Date: 2019-04-23
Authors: Lawrence H Yang; Margaux M Grivel; Bradley Anderson; Genie L Bailey; Mark Opler; Liang Yi Wong; Michael D Stein Journal: J Subst Abuse Treat Date: 2019-01-09